Literature DB >> 6322423

Mx-dependent resistance to influenza viruses is induced by mouse interferons alpha and beta but not gamma.

P Staeheli, M A Horisberger, O Haller.   

Abstract

In cells derived from congenic BALB.A2G-Mx mice carrying the resistance gene Mx, but not in cells from BALB/c mice lacking Mx, mouse interferons alpha and beta induced the synthesis of a unique cellular protein that was associated with an efficient antiviral state with selectivity for influenza viruses. In contrast, native or recombinant mouse interferon gamma failed to efficiently protect Mx-bearing cells against influenza viruses and did not noticeably induce the synthesis of the Mx-associated protein, although interferon gamma was as effective as interferons alpha and beta in protecting BALB.A2G-Mx and BALB/c cells against the rhabdovirus VSV. These results demonstrate that different types of interferons differentially regulate the expression of the Mx gene and thereby induce distinct antiviral states.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322423     DOI: 10.1016/0042-6822(84)90050-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  28 in total

1.  Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation.

Authors:  P Staeheli; R Grob; E Meier; J G Sutcliffe; O Haller
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

2.  Beta and gamma interferons act synergistically to produce an antiviral state in cells resistant to both interferons individually.

Authors:  J A Lewis; A Huq; B Shan
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

3.  Interferon-regulated influenza virus resistance gene Mx is localized on mouse chromosome 16.

Authors:  P Staeheli; D Pravtcheva; L G Lundin; M Acklin; F Ruddle; J Lindenmann; O Haller
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

4.  Functional Comparison of Mx1 from Two Different Mouse Species Reveals the Involvement of Loop L4 in the Antiviral Activity against Influenza A Viruses.

Authors:  Judith Verhelst; Jan Spitaels; Cindy Nürnberger; Dorien De Vlieger; Tine Ysenbaert; Peter Staeheli; Walter Fiers; Xavier Saelens
Journal:  J Virol       Date:  2015-08-19       Impact factor: 5.103

5.  Studies in the in vivo expression of the influenza resistance gene Mx by in-situ hybridisation.

Authors:  K C Chang; G Goldspink; J Lida
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Transcriptional activation of the mouse Mx gene by type I interferon.

Authors:  P Staeheli; P Danielson; O Haller; J G Sutcliffe
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

7.  A family of interferon-induced Mx-related mRNAs encodes cytoplasmic and nuclear proteins in rat cells.

Authors:  E Meier; J Fäh; M S Grob; R End; P Staeheli; O Haller
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

8.  Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.

Authors:  Shin-Ichiro Kawamoto; Kenji Oritani; Hideo Asada; Isao Takahashi; Jun Ishikawa; Hitoshi Yoshida; Masahide Yamada; Naoko Ishida; Hidetoshi Ujiie; Hiroaki Masaie; Yoshiaki Tomiyama; Yuji Matsuzawa
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling.

Authors:  Dirk Holzinger; Carl Jorns; Silke Stertz; Stéphanie Boisson-Dupuis; Robert Thimme; Manfred Weidmann; Jean-Laurent Casanova; Otto Haller; Georg Kochs
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

10.  Type I interferon receptor-independent and -dependent host transcriptional responses to mouse hepatitis coronavirus infection in vivo.

Authors:  Matthijs Raaben; Marian J A Groot Koerkamp; Peter J M Rottier; Cornelis A M de Haan
Journal:  BMC Genomics       Date:  2009-08-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.